Results for XBiotech

Add to feed Create your own feed

Most relevant

@JanssenGlobal paying @XBiotech_USA  up to $1.35B to license its IL-1a inhibitor

XBiotech sells bermekimab to Janssen for $750M plus potential milestones $XBIT $JNJ

XBiotech's stock plunges after IDMC recommends ending late-stage trial of colorectal cancer treatment

Recall, this is $XBIT --> XBiotech cancer drug survival claim falls apart under scrutiny. Awful. via @TheStreet 

XBiotech drops after ESMO says data 'cannot be relied upon' $XBIT: Full Story

XBiotech shares drop more than 25% after study data 'irregularities' found

XBiotech prices IPO. 4M shares at $19/share. $XBIT

Loading
Loading